Meeting
2022 ASCO Annual Meeting
Prevalence of ocular comorbidities in patients with multiple myeloma: An analysis of U.S. claims data.
Authors
Sikander Ailawadhi
Mayo Clinic, Jacksonville, FL
Sikander Ailawadhi , Qiufei Ma , Jessica J. Jalbert , Mo Zhou , Zheng-Yi Zhou , Nathaniel Downes , Allison Briggs , Lei Chi , Christian Hampp , Xue Song , Irene Noguera-Troise , Jonathan Weyne , Glenn Scott Kroog , Karen Rodriguez-Lorenc
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8038)
DOI
10.1200/JCO.2022.40.16_suppl.8038
Abstract #
8038
Poster Bd #
462
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Real-world overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line (1L) systemic therapy (tx): Results from IMPACT UC II.
First Author: Mehmet Asim Bilen
Poster
2023 ASCO Annual Meeting
Investigation into aberrant B cell repertoire in myeloma on humoral immunity and patient survival.
First Author: Lakshmi Bhavani Potluri
Poster
2023 ASCO Genitourinary Cancers Symposium
Treatment patterns, indicators of receiving systemic treatment, and clinical outcomes in metastatic urothelial carcinoma: A retrospective analysis of real-world data in Germany.
First Author: Guenter Niegisch
Poster
2024 ASCO Genitourinary Cancers Symposium
Real world experience of FGFR gene alterations and clinical outcomes in advanced/metastatic urothelial cancer in Japan: MONSTAR-SCREEN database study.
First Author: Nobuaki Matsubara